Literature DB >> 1524813

Serum cathepsin B-like activity as a potential marker of laryngeal carcinoma.

T Krecicki1, M Siewiński.   

Abstract

Early detection and reliable monitoring of treatment constitute one of the most challenging problems in oncology. For this reason, we studied the potential value of serum cathepsin B-like activity as a possible marker of laryngeal carcinoma. The results indicate that serial analyses of this parameter have predictive value in the assessment of surgical treatment of laryngeal carcinoma. Activity of the enzyme reveals a progressive increment which could be associated with increased severity of the neoplasm present. The serum level of the cathepsin B-like activity remained close to zero in the control group of healthy volunteers and patients with inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1524813     DOI: 10.1007/bf00714496

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  An improved color reagent for use in Barrett's assay of Cathepsin B.

Authors:  A J Barrett
Journal:  Anal Biochem       Date:  1976-11       Impact factor: 3.365

Review 2.  [Cystatins].

Authors:  M Warwas; G Sawicki
Journal:  Postepy Biochem       Date:  1987

3.  Elevated serum cathepsin B1-like activity in women with neoplastic disease.

Authors:  R J Pietras; C M Szego; C E Mangan; B J Seeler; M M Burtnett
Journal:  Gynecol Oncol       Date:  1979-02       Impact factor: 5.482

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  A thiol protease inhibitor released from cultured human malignant melanoma cells.

Authors:  Y Nishida; H Sumi; H Mihara
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

6.  Secretion of proteinases from malignant and nonmalignant human breast tissue.

Authors:  A D Recklies; K J Tiltman; T A Stoker; A R Poole
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

7.  Serum alkaline-stable acid thiol proteinase--a possible marker for primary liver carcinoma.

Authors:  V Dufek; B Matous; V Král
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

8.  Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapy.

Authors:  R G Fish; A K Yap; K James
Journal:  Clin Biochem       Date:  1982-02       Impact factor: 3.281

9.  Increased cathepsin B activity in human lung tumors.

Authors:  E Krepela; E Kasafírek; K Novák; J Viklický
Journal:  Neoplasma       Date:  1990       Impact factor: 2.575

10.  Inhibition of the cathepsin B like proteinase by a low molecular weight cysteine-proteinase inhibitor from ascitic fluid and plasma alpha 2 macroglobulin.

Authors:  M Pagano; D Keppler; V Fumeron-Dalet; R Engler
Journal:  Biochem Cell Biol       Date:  1986-12       Impact factor: 3.626

View more
  1 in total

1.  Cysteine peptidase and its inhibitor activity levels and vitamin E concentration in normal human serum and colorectal carcinomas.

Authors:  Robert Szwed; Zygmunt Grzebieniak; Yousif Saleh; Godwin Bwire Ekonjo; Maciej Siewinski
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.